IMAX Corporation: 10-Q filed 2024-04-25
What IMAX Corporation reported in its quarterly report filed 2024-04-25 (fiscal Q1 2024): 44 published measures, 89 facts as tagged in accession 0000950170-24-047943.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2024-04-25
- Fiscal period
- fiscal Q1 2024
- Accession
- 0000950170-24-047943 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IMAX Corporation filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 824,140,000 | USD | |
| At 2023-12-31 | 814,669,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 490,761,000 | USD | |
| At 2023-12-31 | 469,080,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 258,802,000 | USD | |
| At 2023-12-31 | 273,141,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 81,017,000 | USD | |
| At 2023-12-31 | 76,200,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 3,274,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 2,454,000 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | -10,968,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 21,218,000 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 1,104,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 364,000 | USD | 90 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 79,123,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 86,946,000 | USD | 90 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 79,123,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 86,946,000 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 22,794,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | -15,037,000 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | -7,140,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | -4,281,000 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | -297,284,000 | USD | |
| At 2023-12-31 | -292,845,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 52,501,000 | shares | 91 |
| 2023-01-01 to 2023-03-31 | 54,064,000 | shares | 90 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 53,406,000 | shares | 91 |
| 2023-01-01 to 2023-03-31 | 54,991,000 | shares | 90 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 0.06 | USD/shares | 91 |
| 2023-01-01 to 2023-03-31 | 0.05 | USD/shares | 90 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 0.06 | USD/shares | 91 |
| 2023-01-01 to 2023-03-31 | 0.04 | USD/shares | 90 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 5,159,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 4,885,000 | USD | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 240,450,000 | USD | |
| At 2023-12-31 | 243,299,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 4,700,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 5,100,000 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 12,067,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 11,401,000 | USD | 90 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 1,945,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 1,767,000 | USD | 90 |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 52,815,000 | USD | |
| At 2023-12-31 | 52,815,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 140,579,000 | USD | |
| At 2023-12-31 | 136,259,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 17,856,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 3,656,000 | USD | 90 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 36,153,000 | USD | |
| At 2023-12-31 | 31,584,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 46,889,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 50,051,000 | USD | 90 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 31,257,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 34,148,000 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 2,187,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 1,855,000 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 52,622,200 | shares | |
| At 2023-12-31 | 53,260,276 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | -13,320,000 | USD | |
| At 2023-12-31 | -12,081,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 332,730,000 | USD | |
| At 2023-12-31 | 344,931,000 | USD | |
| At 2023-03-31 | 333,108,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 10,263,000 | USD | |
| At 2023-12-31 | 10,599,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 12,353,000 | USD | |
| At 2023-12-31 | 12,702,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 34,902,000 | USD | |
| At 2023-12-31 | 35,022,000 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 7,700,000 | USD | |
| At 2023-12-31 | 8,000,000 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-03-31 | 12,521,000 | USD | |
| At 2023-12-31 | 12,521,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 10,579,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 10,008,000 | USD | 90 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 5,420,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 5,123,000 | USD | 90 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 2,035,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 4,424,000 | USD | 90 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 1,343,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 1,074,000 | USD | 90 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 571,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | -193,000 | USD | 90 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 723,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 971,000 | USD | 90 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | 4,502,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | -12,374,000 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-03-31 | -7,547,000 | USD | 91 |
| 2023-01-01 to 2023-03-31 | 513,000 | USD | 90 |
Inspect the source
- Entity
- IMAX Corporation / CIK 0000921582
- Captured
- 2026-09-20T05:08:04.965Z
- SEC response SHA-256
1c9fb15a2849334ccf704de795a89e3899f30b1866fe6c4a6dc8d104a2b50e18
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000921582.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))